Multiplex cytokine analysis of Werner syndrome

Intractable and Rare Diseases Research

Volumn 4, Issue 4, 2015, Pages 190-197

  Goto, Makoto ^a,b,c   Hayata, Koichiro ^b   Chiba, Junji ^b   Matsuura, Masaaki ^d,e   Iwaki Egawa, Sachiko ^f   Watanabe, Yasuhiro ^f  

^a TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Nerima Hikarigaoka Hospital   (Japan)

^d CANCER INSTITUTE   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

^f HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Ageing; Chemokine; CRP; Cytokine; Inflammageing; Werner syndrome

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGHLY SENSITIVE C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; AGING; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MACROPHAGE; MALE; MIDDLE AGED; MONOCYTE; MULTIPLEX ASSAY; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; WERNER SYNDROME;

EID: 84973566105     PISSN: 21863644     EISSN: 2186361X     Source Type: Journal    
DOI: 10.5582/irdr.2015.01035     Document Type: Article

References (33)

1. Goto M, Miller RW. From premature gray hair to helicase- Werner syndrome: Implications for aging and cancer. In: Monograph on Cancer Research. No.49, Japan Scientific Societies press & Karger, Tokyo, Japan, 2001.
2. Goto M, Sugimoto K, Hayashi S, Ogino T, Sugimoto M, Furuichi Y, Matsuura M, Ishikawa Y, Iwaki-Egawa S, Watanabe Y. Aging-associated inflammation in healthy Japanese individuals and patients with Werner syndrome. Exp Gerontol. 2012; 47:936-939.
3. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular diseases. Circ Res. 2004; 95:858-866.
4. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: Distinct responses in newborns and the elderly. Immunity. 2012; 37:771-783.
5. Kolattukudy PE, Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res. 2012; 110:174-189.
6. Lee P, Werner CD, Kebebew E, Celi FS. Functional thermogenic beige adipogenesis is inducible in human neck fat. Int J Obes (Lond). 2014; 38:170-176.
7. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci. 2000; 908:244-254.
8. Goto M. Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? BioSci Trends. 2008; 2:218-230.
9. Balkwill F, Coussens LM. Cancer: An inflammatory link. Nature. 2004; 431:405-406.
10. Shaw AC, Goldstein DR, Montgomery RR. Agedependent dysregulation of innate immunity. Nat Rev Immunol. 2013; 13:875-887.
11. Mold C, Rodriguez W, Rodic-Polic B, Du Clos TW. C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. J Immunol. 2002; 169:7019-7025.
12. Shurin GV, Yurkovetsky ZR, Chatta GS, Tourkova IL, Shurin MR, Lokshin AE. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine. 2007; 39:123-129.
13. Kim HO, Kim HS, Youn JC, Shin EC, Park S. Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays. J Transl Med. 2011; 9:113.
14. Miles EA, Rees D, Baneriee T, Cazzola R, Lewis S, Wood R, Oates R, Tallant A, Cestaro B, Yagoob P, Wahle KW, Calder PC. Age-related increase in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis. 2008; 196:298-305.
15. Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Inteferon Cytokine Res. 1999; 19:1179-1182.
16. Antonelli A, Rotondi M, Fallahi P, Ferrari SM, Paolicchi A, Romaqnani P, Serio M, Ferrannini E. Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine. 2006; 34:32-38.
17. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes N, Muller-Hermelink HK, Steinmann GG. Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mech Ageing Dev. 1984; 28:47-55.
18. Akaike H. Information theory and extension of the maximum likelihood principle. B.N. Petrov, F. Csaki (Eds.), Proceedings of the 2nd International Symposium on Information Theory, Akademiai Kiado, Budapest, 1973; pp. 267-281.
19. Ihaka R, Gentleman R. R: A language for data analysis and graphics. J Comp Grap Stat. 1996; 5:299-314.
20. Sakurai T, Iimuro S, Araki A, Umegaki H, Ohashi Y, Yokono K, Lto H. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus. Gerontology. 2010; 56:141-149.
21. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351:2599-2610.
22. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J, Doi Y, Okubo K, Oishi Y, Shikata K, Yonemoto K, Maebuchi D, Ibayashi S, Iida M. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: The Hisayama study. Stroke. 2006; 37:27-32.
23. Ishikawa J, Tamura Y, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K. Low-grade inflammation is a risk factor for clinical stroke events in addition to silentcerebral infarcts in Japanese older hypertensives: The Jichi Medical School ABPM Study, wave 1. Stroke. 2007; 38:911-917.
24. Kishimoto T. IL-6: From its discovery to clinical applications. Int Immunol. 2010; 22:347-352.
25. Kaplan MH, Volanakis JE. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive proteinwith pneumococcal C-polysaccharide and with the choline phosphatides, lecithin andsphingomyelin. J Immunol. 1974; 112:2135-2147.
26. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med. 1999; 190:585-590.
27. Kim S, Elkon KB, Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity. 2004; 21:643-653.
28. Du Clos TW. C-reactive protein as a regulator of autoimmunity and inflammation, Arthritis Rheum. 2003; 48:1475-1477.
29. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8:958-969.
30. Harris J, De Haro SA, Master SS, Keane J, Roberts EA, Delgado M, Deretic V. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity. 2007; 27:505-517.
31. Mansfield AS, Nevala WK, Dronca RS, Leontovich AA, Shuster L, Markovic SN. Normal ageing is associated with an increase in Th2 cells, MCP-1(CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes. Clin Exp Immunol. 2012; 170:186-193.
32. Loke P, Gallagher I, Nair MG, Zang X, Brombacher F, Mohrs M, Allison JP, Allen JE. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol. 2007; 179:3926-3936.
33. Goto M. Emerging concept of ageing: Inflammageing. Inflammation and Regeneration. 2009; 29:249-257.